ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Robert Wesolowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.